Triflupromazine
Back to searchMolecule Structure
Scientific Name
Triflupromazine
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00508
http://www.drugbank.ca/drugs/DB00508
Brand Name(s)
Fluopromazine, Nivoman, Vesprin, Vetame
Company Owner(s)
Apothecon Inc Div Bristol Myers Squibb, Bristol Myers Squibb Co, Apothecon Sub Bristol Myers Squibb Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL44085 | ||
| PharmGKB | PA451773 | ||
| Human Metabolome Database | HMDB0014650 | ||
| DrugBank | DB00508 | ||
| PubChem: Thomson Pharma | 14925496 | ||
| PubChem | 5568 | ||
| Mcule | MCULE-9151902507 | ||
| LINCS | LSM-3421 | ||
| Nikkaji | J2.957B | ||
| BindingDB | 67544 | ||
| EPA CompTox Dashboard | DTXSID9023704 | ||
| DrugCentral | 2742 | ||
| Brenda | 6695 | 151912 | 142792 |
| Guide to Pharmacology | 4330 | ||
| rxnorm | TRIFLUPROMAZINE | TRIFLUPROMAZINE HYDROCHLORIDE | |
| ChEBI | 9711 | ||
| ZINC | ZINC000000538507 |
